BN Business News
Add your company to Business Communicator →

Business · 10/01/2014Updated: 10/17/2026 · 1 min read

FDA Announces Enforcement Action Against Misbranded Codeine-Containing Prescription Drugs

The FDA plans to take enforcement action against unapproved and misbranded oral and injectable prescription drugs containing codeine, posing serious risks of addiction and competing with approved products, which may lack essential safety information.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →